undamentalytics Newsletter

Leonard Braden Michael: insider trades

Director, 10% owner, Other at 10 companies we cover. 39 open-market purchases and 30 sales not made under a pre-set plan, reported from March 14, 2012 to October 5, 2026.

Would copying Leonard Braden Michael’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 5 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on March 15, 2012 into $35,521 by November 2, 2026, +9.1% a year. The copy held shares only 19% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $16,201, +3.4% a year (the S&P 500 held throughout made $69,366, +14.2% a year). Beta against the index was 0.14. Twelve months after each report, the average purchase was +98.8% against the S&P 500 (median +11.8%), and 60% beat it. Measured from the trade date, the insider’s own timing, the average was +124.0%. After their sales, the shares moved −10.6% against the index over 12 months on average (a negative figure means selling was the right call); 63% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k$60.0k 20122014201620182020202220242026 $69.4k$35.5k$16.2k
Copying Leonard Braden MichaelS&P 500, same days investedS&P 500, held throughout $10,000 copying Leonard Braden Michael’s open-market purchases from March 15, 2012, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+9.1%
S&P 500, same days invested
+3.4% (held throughout +14.2%)
Time in shares
19%
Sharpe ratio (S&P 500)
0.35 (0.78)
Biggest drop (S&P 500)
−51% (−34%)
Market sensitivity (beta)
0.14
Purchases copied
5

Trade by trade

Leonard Braden Michael: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 5 −10.8% −15.4% 20% 2 — — Not enough years
Purchases, 6 months after the report 5 +83.2% −5.4% 40% 2 — — Not enough years
Purchases, 12 months after the report 5 +98.8% +11.8% 60% 2 — — Not enough years
Purchases, 12 months after the trade 2 +124.0% +124.0% 50% 2 — — Not enough years
Sales, 3 months after the report 24 +0.5% −4.4% 58% 7 −0.30 0.78 No reliable evidence
Sales, 12 months after the report 24 −10.6% −20.7% 63% 7 −0.36 0.73 No reliable evidence
Sales, 12 months after the trade 24 −10.0% −18.3% 63% 7 −0.57 0.59 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Build-a-bear Workshop Inc BBW —719March 14, 2012October 2, 2017
Enliven Therapeutics, Inc. ELVN —44April 25, 2022January 4, 2023
Astrotech Corp ASTC —71August 25, 2022October 7, 2025
Aclaris Therapeutics, Inc. ACRS —71June 13, 2024April 27, 2026
Retractable Technologies Inc RVP —52May 2, 2022December 29, 2022
Onkure Therapeutics, Inc. OKUR —50May 16, 2024September 26, 2024
An2 Therapeutics, Inc. ANTX —12August 14, 2024June 16, 2025
Disc Medicine, Inc. IRON —11April 13, 2022October 27, 2022
Tectonic Therapeutic, Inc. TECX —10May 15, 2024May 15, 2024
Outset Medical, Inc. OM —10October 5, 2026October 5, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
October 5, 2026October 1, 2026 OM Purchase $870,260 not yetnot yetnot yet
April 27, 2026April 23, 2026 ACRS Sale $1,359,000 not yetnot yetnot yet
October 7, 2025October 3, 2025 ASTC Sale $1,624,961 −29.7%+19.3%−1.3%
June 16, 2025May 28, 2025 ANTX Sale $218,000 not yetnot yetnot yet
May 30, 2025May 28, 2025 ANTX Sale $2,872,460 not yetnot yetnot yet
September 26, 2024September 24, 2024 OKUR Purchase $144,855 not yetnot yetnot yet
September 19, 2024September 17, 2024 OKUR Purchase $76,336 not yetnot yetnot yet
September 16, 2024September 12, 2024 OKUR Purchase $483,810 not yetnot yetnot yet
August 14, 2024August 14, 2024 ANTX Purchase $1,560,000 not yetnot yetnot yet
August 14, 2024August 13, 2024 OKUR Purchase $379,848 not yetnot yetnot yet
August 5, 2024August 2, 2024 ACRS Purchase $471,603 not yetnot yetnot yet
July 31, 2024July 30, 2024 ACRS Purchase $358,849 not yetnot yetnot yet
July 22, 2024July 18, 2024 ACRS Purchase $201,670 not yetnot yetnot yet
July 5, 2024July 2, 2024 ACRS Purchase $405,829 not yetnot yetnot yet
July 1, 2024June 27, 2024 ACRS Purchase $1,741,845 not yetnot yetnot yet
June 18, 2024June 14, 2024 ACRS Purchase $629,650 not yetnot yetnot yet
June 13, 2024June 11, 2024 ACRS Purchase $1,781,768 not yetnot yetnot yet
May 16, 2024May 14, 2024 OKUR Purchase $639,578 not yetnot yetnot yet
May 15, 2024May 13, 2024 TECX Purchase $972,761 not yetnot yetnot yet
January 4, 2023January 4, 2023 ELVN Sale $5,000,000 +15.3%−51.8%−46.0%
December 30, 2022December 30, 2022 ELVN Sale $80,800 +36.6%−32.0%−36.4%
December 29, 2022December 29, 2022 RVP Sale $4,800,000 not yetnot yetnot yet
December 29, 2022December 28, 2022 ELVN Sale $80,800 +27.5%−36.4%−41.8%
December 27, 2022December 22, 2022 ELVN Sale $203,000 +30.5%−41.8%−37.6%
December 2, 2022December 2, 2022 ASTC Purchase $64,930 +14.3%−46.7%not yet
November 30, 2022November 28, 2022 RVP Sale $505,520 not yetnot yetnot yet
November 25, 2022November 23, 2022 ASTC Purchase $24,750 not yetnot yetnot yet
November 18, 2022November 16, 2022 ASTC Purchase $144,589 not yetnot yetnot yet
October 27, 2022October 26, 2022 IRON Sale $47,025 not yetnot yetnot yet
October 18, 2022October 14, 2022 ASTC Purchase $82,745 not yetnot yetnot yet
September 27, 2022September 23, 2022 ASTC Purchase $156,489 not yetnot yetnot yet
September 7, 2022September 1, 2022 ASTC Purchase $117,248 not yetnot yetnot yet
August 25, 2022August 23, 2022 ASTC Purchase $219,047 not yetnot yetnot yet
June 21, 2022June 16, 2022 ELVN Purchase $92,351 not yetnot yetnot yet
June 7, 2022June 3, 2022 ELVN Purchase $38,163 not yetnot yetnot yet
May 25, 2022May 23, 2022 RVP Purchase $252,889 not yetnot yetnot yet
May 19, 2022May 17, 2022 RVP Purchase $534,911 not yetnot yetnot yet
May 18, 2022May 16, 2022 ELVN Purchase $50,493 −17.7%+319.2%not yet
May 16, 2022May 12, 2022 RVP Purchase $553,740 not yetnot yetnot yet
May 11, 2022May 9, 2022 RVP Purchase $280,924 not yetnot yetnot yet
May 2, 2022April 28, 2022 RVP Purchase $1,603,392 not yetnot yetnot yet
April 25, 2022April 21, 2022 ELVN Purchase $783,840 −12.9%+230.5%+268.9%
April 13, 2022April 11, 2022 IRON Purchase $1,337,213 not yetnot yetnot yet
October 2, 2017September 28, 2017 BBW Sale $248,650 −4.2%−26.6%−20.4%
September 26, 2017September 22, 2017 BBW Sale $429,952 −7.5%−20.5%−22.1%
September 21, 2017September 19, 2017 BBW Sale $201,808 −3.4%−22.1%−17.5%
September 18, 2017September 14, 2017 BBW Sale $719,542 −4.5%−17.5%−19.0%
August 17, 2015August 13, 2015 BBW Sale $1,480,803 −33.3%−48.0%−47.8%
March 11, 2015March 9, 2015 BBW Sale $247,471 −24.8%−31.5%−30.4%
November 18, 2014November 17, 2014 BBW Sale $379,208 +10.2%−36.8%−34.1%
November 13, 2014November 11, 2014 BBW Sale $339,996 +10.7%−30.2%−25.6%
November 7, 2014November 5, 2014 BBW Sale $580,640 +12.9%−20.9%−22.7%
November 3, 2014October 31, 2014 BBW Sale $257,100 +19.7%−23.0%−17.0%
October 30, 2014October 28, 2014 BBW Sale $3,070,350 +18.8%−17.0%+2.6%
August 28, 2014August 26, 2014 BBW Sale $1,020,970 +54.1%+49.9%+48.2%
June 2, 2014May 29, 2014 BBW Sale $1,236,291 −15.1%+1.1%+3.9%
May 28, 2014May 23, 2014 BBW Sale $883,389 −7.5%+3.9%+3.0%
May 21, 2014May 19, 2014 BBW Sale $602,686 −17.3%+10.2%+9.3%
May 15, 2014May 13, 2014 BBW Sale $423,898 −24.3%+10.7%+11.9%
May 12, 2014May 9, 2014 BBW Sale $1,037,051 −19.2%+11.9%+12.8%
May 8, 2014May 6, 2014 BBW Sale $1,373,327 −21.4%+12.8%+8.5%
November 18, 2013November 15, 2013 BBW Sale $45,710 −11.6%+82.1%+79.7%
June 15, 2012June 14, 2012 BBW Purchase $101,717 not yetnot yetnot yet
June 11, 2012June 8, 2012 BBW Purchase $217,000 not yetnot yetnot yet
June 4, 2012May 31, 2012 BBW Purchase $145,375 not yetnot yetnot yet
May 29, 2012May 24, 2012 BBW Purchase $81,475 not yetnot yetnot yet
May 23, 2012May 22, 2012 BBW Purchase $234,500 not yetnot yetnot yet
May 10, 2012May 8, 2012 BBW Purchase $724,000 −15.4%+11.8%not yet
March 14, 2012March 12, 2012 BBW Purchase $551,967 −22.3%−20.7%−20.8%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Leonard Braden Michael traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.